Leading provider of evidence-based analytics and services to reduce unwarranted and costly clinical variation
Acquired by:
Global Healthcare Exchange in 2020 Investors:
Bessemer Venture Partners, Blueprint Health, FCA Venture Partners, F-Prime Capital Partners, Health Insight Capital, Heritage Group